Clinical Trial

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Study acronym: BE CARING
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2025-03-15; most recent amendment 2026-07-16.
Status change: Not Yet Recruiting → Recruiting 2025-05-16
Trial Details
NCT Number NCT06888193
Lead Sponsor UCB Biopharma SRL
Conditions Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, Hidradenitis Suppurativa
Enrollment 20 participants
Start Date 2025-11-05
Primary Completion 2027-05-03 (estimated)
Study Completion 2027-05-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-17